kainic acid has been researched along with Parkinsonian Disorders in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelsey, JE; Neville, C | 1 |
| Bai, Y; Bian, GL; Cao, R; Chen, LW; Wang, YQ | 1 |
| Auburger, G; Dehorter, N; Gispert, S; Hammond, C; Klinkenberg, M; Lopez, C; Lozovaya, N; Mdzomba, BJ; Michel, FJ; Tsintsadze, T; Tsintsadze, V | 1 |
| Kojima, J; Matsumura, M | 1 |
| Henderson, JM; Watson, SH | 1 |
| Bezin, L; Christopherson, PL; Foster, JA; Groc, L; Levine, RA | 1 |
| Chang, JW; Chung, SS; Jeon, MF; Lee, BH; Yang, JS | 1 |
| Chang, JW; Cho, YH; Ha, Y; Jeon, MF; Lee, BH; Park, YG | 1 |
| Aziz, TZ; Jenkinson, E; Miall, C; Nandi, D; Stein, JF | 1 |
| Chang, JW; Hwang, YS; Lee, BB; Shim, I | 1 |
| Alvarez-Erviti, L; Barroso-Chinea, P; Blesa, FJ; Guridi, J; Lanciego, JL; Obeso, JA; Rodríguez-Oroz, MC; Smith, Y | 1 |
| Chen, L; Li, S; Liu, Z; Tian, Z; Wang, Y | 1 |
| Gmiro, VE; Gorbunova, LV; Lukomskaia, NIa; Rukoiatkina, NI | 1 |
13 other study(ies) available for kainic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
The effects of the β-lactam antibiotic, ceftriaxone, on forepaw stepping and L-DOPA-induced dyskinesia in a rodent model of Parkinson's disease.
Topics: Animals; Anti-Bacterial Agents; Antiparkinson Agents; Ceftriaxone; Central Nervous System Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Transporter 2; Forelimb; Kainic Acid; Levodopa; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats, Long-Evans | 2014 |
Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
Topics: Acetylcholine; Animals; Apoptosis; Basal Nucleus of Meynert; Brain-Derived Neurotrophic Factor; Cell Count; Cell Survival; Choline O-Acetyltransferase; Dopamine; Excitatory Amino Acid Agonists; Kainic Acid; Male; Nerve Degeneration; Neurons; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptor, Nerve Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase; Up-Regulation | 2008 |
Subthalamic lesion or levodopa treatment rescues giant GABAergic currents of PINK1-deficient striatum.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Electric Conductivity; Excitatory Amino Acid Agonists; Female; gamma-Aminobutyric Acid; Immunohistochemistry; Kainic Acid; Levodopa; Male; Mice; Mice, Knockout; Neurons; Parkinsonian Disorders; Patch-Clamp Techniques; Protein Kinases; Subthalamic Nucleus | 2012 |
The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Afferent Pathways; Animals; Basal Ganglia; Brain Stem; Cerebral Cortex; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Efferent Pathways; Kainic Acid; Macaca; Male; Models, Neurological; MPTP Poisoning; Muscimol; Neurons; Parkinsonian Disorders; Pons; Psychomotor Performance; Stereotaxic Techniques; Substantia Nigra; Tegmentum Mesencephali | 2001 |
Convulsive and postural effects of lesioning the mid-substantia nigra pars reticulata in naïve and 6-hydroxydopamine lesioned rats.
Topics: Animals; Apomorphine; Behavior, Animal; Cortical Synchronization; Disease Models, Animal; Dopamine Agonists; Female; Functional Laterality; Kainic Acid; Motor Activity; Oxidopamine; Parkinsonian Disorders; Perceptual Disorders; Posture; Rats; Rats, Sprague-Dawley; Rotation; Seizures; Substantia Nigra | 2003 |
Kainic acid lesion-induced nigral neuronal death.
Topics: Animals; Biopterins; Cell Death; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Functional Laterality; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intraventricular; Kainic Acid; Male; Neurons; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2003 |
Effect of subthalamic lesion with kainic acid on the neuronal activities of the basal ganglia of rat parkinsonian models with 6-hydroxydopamine.
Topics: Action Potentials; Animals; Basal Ganglia; Globus Pallidus; Kainic Acid; Male; Neural Pathways; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Subthalamic Nucleus | 2003 |
Effect of ipsilateral subthalamic nucleus lesioning in a rat parkinsonian model: study of behavior correlated with neuronal activity in the pedunculopontine nucleus.
Topics: Adrenergic Agents; Animals; Basal Ganglia; Behavior, Animal; Corpus Striatum; Excitatory Amino Acid Agonists; Functional Laterality; Kainic Acid; Locomotion; Mesencephalon; Neurons; Oxidopamine; Parkinsonian Disorders; Pons; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Subthalamic Nucleus | 2003 |
Pedunculopontine nucleus.
Topics: Animals; Corpus Striatum; Dominance, Cerebral; Dopamine; Electric Stimulation Therapy; Humans; Kainic Acid; Neural Pathways; Neurons; Oxidopamine; Parkinsonian Disorders; Pedunculopontine Tegmental Nucleus; Rats; Substantia Nigra; Subthalamic Nucleus | 2004 |
Effect of subthalamic nucleus lesions in a 6-hydroxydopamine-induced rat parkinsonian model: behavioral and biochemical studies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dominance, Cerebral; Dopamine; Globus Pallidus; Kainic Acid; Male; Motor Activity; Motor Skills; Neural Pathways; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Subthalamic Nucleus | 2006 |
Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dyskinesia, Drug-Induced; Functional Laterality; Intralaminar Thalamic Nuclei; Kainic Acid; Levodopa; Macaca fascicularis; Male; Parkinsonian Disorders; Stereotaxic Techniques | 2008 |
Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions.
Topics: Afferent Pathways; Animals; Biomarkers; Dopamine; Excitatory Amino Acid Agonists; Glutamic Acid; Kainic Acid; Male; Medial Forebrain Bundle; Microinjections; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Subthalamic Nucleus; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2000 |
[Ability of novel non-competitive glutamate receptor blocking agents to weaken motor disorders in animals].
Topics: Animals; Anticonvulsants; Ataxia; Benzene Derivatives; Catalepsy; Cations; Cyclohexanes; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Haloperidol; Kainic Acid; Mice; N-Methylaspartate; Parkinsonian Disorders; Seizures; Structure-Activity Relationship | 2001 |